Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Washington
Memorial Sloan Kettering Cancer Center